4.3 Article

Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine

Journal

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
Volume 68, Issue 6, Pages 1139-1152

Publisher

WILEY
DOI: 10.1002/bab.2035

Keywords

biocompatibility; cytotoxicity; nanomedicine; nanoparticles; nanotherapeutics; protein corona

Ask authors/readers for more resources

Nanomedicine is a multidisciplinary field with various clinical applications, such as molecular imaging, medical diagnostics, targeted therapy, and image-guided surgery. Efforts are still needed to understand the complex behavior of nanoparticles under physiological conditions and the impact of protein corona on their toxicity and targeting capacity.
Nanomedicine is an interdisciplinary field of research, comprising science, engineering, and medicine. Many are the clinical applications of nanomedicine, such as molecular imaging, medical diagnostics, targeted therapy, and image-guided surgery. Despite major advances during the past 20 years, many efforts must be done to understand the complex behavior of nanoparticles (NPs) under physiological conditions, the kinetic and thermodynamic principles, involved in the rational design of NP. Once administrated in physiological environment, NPs interact with biomolecules and they are surrounded by protein corona (PC) or biocorona. PC can trigger an immune response, affecting NPs toxicity and targeting capacity. This review aims to provide a detailed description of biocorona and of parameters that are able to control PC formation and composition. Indeed, the review provides an overview about the role of PC in the modulation of both cytotoxicity and immune response as well as in the control of targeting capacity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available